Table 2.

Logistic Regression Analyses for the Prediction of Spasm‐Induced NSTE‐ACS

	Simple Regression Analysis			Multiple Regression Analysis
	OR	95% CI	P Value	OR	95% CI	P Value
Age <70 y	3.04	2.31 to 3.98	<0.001	2.19	1.58 to 3.04	<0.001
Male sex	0.90	0.69 to 1.18	0.45
Body mass index <25 kg/m2	0.99	0.77 to 1.28	0.96
Current smoking	1.51	1.17 to 1.95	0.002	1.03	0.76 to 1.40	0.83
Family history of CAD	1.13	0.84 to 1.53	0.43
No hypertension	3.49	2.69 to 4.51	<0.001	2.55	1.90 to 3.41	<0.001
No dyslipidemia	3.25	2.50 to 4.23	<0.001	2.76	2.05 to 3.73	<0.001
No diabetes mellitus	3.27	2.40 to 4.46	<0.001	2.49	1.78 to 3.48	<0.001
No previous MI	7.56	4.18 to 13.7	<0.001	5.37	2.88 to 10.0	<0.001
eGFR >60 mL/min per 1.73 m2	3.32	2.35 to 4.70	<0.001	1.72	1.16 to 2.56	0.009
TIMI risk score ≤2	8.70	5.88 to 11.9	<0.001
LVEF >50%	1.27	0.97 to 1.64	0.077
Nonelevated cardiac biomarkers	2.82	2.16 to 3.68	<0.001	2.84	2.11 to 3.83	<0.001

NSTE‐ACS indicates non–ST‐segment elevation acute coronary syndrome; OR, odds ratio; CAD, coronary heart disease; MI, myocardial infarction; eGFR, estimated glomerular filtration rate; TIMI, Thrombolysis In Myocardial Infarction; LVEF, left ventricular ejection fraction.